131 related articles for article (PubMed ID: 15358037)
1. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization.
Niiyama H; Kai H; Yamamoto T; Shimada T; Sasaki K; Murohara T; Egashira K; Imaizumi T
J Am Coll Cardiol; 2004 Aug; 44(3):661-6. PubMed ID: 15358037
[TBL] [Abstract][Full Text] [Related]
2. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.
Waeckel L; Mallat Z; Potteaux S; Combadière C; Clergue M; Duriez M; Bao L; Gerard C; Rollins BJ; Tedgui A; Levy BI; Silvestre JS
Circ Res; 2005 Mar; 96(5):576-82. PubMed ID: 15718500
[TBL] [Abstract][Full Text] [Related]
3. Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis.
Izumi Y; Kim-Mitsuyama S; Yoshiyama M; Omura T; Shiota M; Matsuzawa A; Yukimura T; Murohara T; Takeya M; Ichijo H; Yoshikawa J; Iwao H
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1877-83. PubMed ID: 15976330
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
5. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104
[TBL] [Abstract][Full Text] [Related]
6. Tetrapeptide AcSDKP induces postischemic neovascularization through monocyte chemoattractant protein-1 signaling.
Waeckel L; Bignon J; Liu JM; Markovits D; Ebrahimian TG; Vilar J; Mees B; Blanc-Brude O; Barateau V; Le Ricousse-Roussanne S; Duriez M; Tobelem G; Wdzieczak-Bakala J; Lévy BI; Silvestre JS
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):773-9. PubMed ID: 16410461
[TBL] [Abstract][Full Text] [Related]
7. CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia.
Tang G; Charo DN; Wang R; Charo IF; Messina L
J Vasc Surg; 2004 Oct; 40(4):786-95. PubMed ID: 15472609
[TBL] [Abstract][Full Text] [Related]
8. Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin.
Egami K; Murohara T; Aoki M; Matsuishi T
J Leukoc Biol; 2006 May; 79(5):971-6. PubMed ID: 16641139
[TBL] [Abstract][Full Text] [Related]
9. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.
Stabile E; Burnett MS; Watkins C; Kinnaird T; Bachis A; la Sala A; Miller JM; Shou M; Epstein SE; Fuchs S
Circulation; 2003 Jul; 108(2):205-10. PubMed ID: 12821542
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.
Liu Q; Chen Z; Terry T; McNatt JM; Willerson JT; Zoldhelyi P
Vasc Endovascular Surg; 2009; 43(5):433-43. PubMed ID: 19628514
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
12. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
Koga M; Kai H; Egami K; Murohara T; Ikeda A; Yasuoka S; Egashira K; Matsuishi T; Kai M; Kataoka Y; Kuwano M; Imaizumi T
Biochem Biophys Res Commun; 2008 Jan; 365(2):279-84. PubMed ID: 17991428
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
[TBL] [Abstract][Full Text] [Related]
14. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
15. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
[TBL] [Abstract][Full Text] [Related]
16. Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice.
Yang YG; Guan H; Liu CW; Li YJ
Chin Med J (Engl); 2009 May; 122(9):1056-60. PubMed ID: 19493440
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
18. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice.
Nakano M; Satoh K; Fukumoto Y; Ito Y; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
Circ Res; 2007 Mar; 100(5):662-9. PubMed ID: 17293480
[TBL] [Abstract][Full Text] [Related]
19. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.
Tojo T; Ushio-Fukai M; Yamaoka-Tojo M; Ikeda S; Patrushev N; Alexander RW
Circulation; 2005 May; 111(18):2347-55. PubMed ID: 15867174
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
